Gene Editing News and Research

RSS

Bayer and Meiogenix join forces to advance agricultural research and development

Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix's proprietary technologies related to plant breeding and genome editing applications.

From Bayer AG 10 Feb 2020

CRISPR-edited immune cells can be safely given to cancer patients

The emergence of CRISPR-Cas9 gene-editing technology has spurred hope in both doctors and patients since it shows promise in treating a multitude of diseases, including cancer. For the first time in the United States, a team of scientists has shown that CRISPR-edited immune cells can be safely used to cancer patients.

9 Feb 2020

Coronavirus - pandemic or not?

The coronavirus strain called 2019-nCoV has been causing widespread illness in China, with 28,276 affected by the virus and over 565 deaths worldwide, mostly in China. As of now, it is already more deadly than the SARS epidemic that raged between 2002 and 2004.

6 Feb 2020

Gene-editing taken to advanced levels in human stem cells

A new study published in the journal Stem Cell Reports in January 2020 reports the use of an adaptation to a commonly used gene editing technology to achieve a more than 900% increase in efficiency.

30 Jan 2020

Death receptor pathway drives resistance to CAR T cell therapy

Some cancer cells refuse to die, even in the face of powerful cellular immunotherapies like CAR T cell therapy, and new research from the Abramson Cancer Center of the University of Pennsylvania is shedding light on why.

30 Jan 2020

Scientists 'knock out' gene in myeloid cells to create listeriosis-immune mice

An international research team which includes specialists from ITMO University has conducted a series of experiments with the goal of studying the immune system and identifying the genes and proteins involved in the response to certain harmful bacteria.

28 Jan 2020

Bone marrow chip provides new strategy for understanding Shwachman-Diamond syndrome

A new research tool that mimics the behavior of diseased bone marrow provides a new strategy for understanding the bone marrow disease, Shwachman-Diamond syndrome, and hopefully, developing new treatments.

28 Jan 2020

Study on axolotl's ability to regenerate might help find ways to restore damaged tissue in humans

The type of salamander called axolotl, with its frilly gills and widely spaced eyes, looks like an alien and has other-worldly powers of regeneration. Lose a limb, part of the heart or even a large portion of its brain? No problem: They grow back.

28 Jan 2020

Synthego adopts good manufacturing practices for highest-quality genome engineering for clinical applications

Synthego, the genome engineering company, today announced it has adopted Good Manufacturing Practice standards to provide academic and industry partners with high-quality reagents for use in clinical research and development.

From Synthego Corporation 23 Jan 2020

Study sheds light on mechanisms that underlie a rare genetic condition

A team of researchers at CHU Sainte-Justine and Université de Montréal has shed light on the mechanisms that underlie a rare genetic condition by creating the first cellular model of the disease.

22 Jan 2020

Horizon Discovery enters into licensing agreement with NGM for GS knockout CHO K1 cell line

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it will license its gene-edited Glutamine Synthetase knockout Chinese Hamster Ovary K1 cell line to NGM Biopharmaceuticals, Inc..

From Revvity 22 Jan 2020

MIT spin-out partners with Cambridge Consultants to co-develop the first Flowfect system

MIT spin-out company Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect system.

22 Jan 2020

Drug profiling and gene editing method open new avenues in the development of CAR T-cell therapy

Researchers have discovered ways to boost CAR T-cell therapy.

21 Jan 2020

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a "one-size-fits-all" cancer therapy.

21 Jan 2020

UT Southwestern study identifies new vulnerability in kidney tumors

A UT Southwestern researcher led a team that identified a new vulnerability in kidney tumors, the 10th most common cause of cancer death in men and women.

17 Jan 2020

Genetically engineered mosquitoes halt Dengue spread

A new study published in the journal PLOS Pathogens in January 2020 reports the development of mosquitoes that have been genetically modified to resist infection by several types of the dengue virus. This is the first time ever that all types of the virus have been targeted by the engineering of the mosquito DNA. Covering all virus types is essential to achieve proper disease control.

16 Jan 2020

Gene Editing News and Research

Bayer and Meiogenix join forces to advance agricultural research and development

CRISPR-edited immune cells can be safely given to cancer patients

Coronavirus - pandemic or not?

Gene-editing taken to advanced levels in human stem cells

Death receptor pathway drives resistance to CAR T cell therapy

Scientists 'knock out' gene in myeloid cells to create listeriosis-immune mice

Bone marrow chip provides new strategy for understanding Shwachman-Diamond syndrome

Study on axolotl's ability to regenerate might help find ways to restore damaged tissue in humans

Synthego adopts good manufacturing practices for highest-quality genome engineering for clinical applications

Study sheds light on mechanisms that underlie a rare genetic condition

Horizon Discovery enters into licensing agreement with NGM for GS knockout CHO K1 cell line

MIT spin-out partners with Cambridge Consultants to co-develop the first Flowfect system

Drug profiling and gene editing method open new avenues in the development of CAR T-cell therapy

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

UT Southwestern study identifies new vulnerability in kidney tumors

Genetically engineered mosquitoes halt Dengue spread

Bath scientists identify promising route to develop new treatments for skin cancer

Horizon Discovery to offer novel base editing technology for clinical research

Leukemic cells are addicted to vitamin B6, research shows

Boosting the number of neurons improves learning and memory of old mice

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News